News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
FDA Meets on Merck & Co., Inc.'s Mevacor; OTC Cholesterol Drug Sought
December 13, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Drug maker Merck will make a third attempt Thursday to convince the government to allow its cholesterol-lowering pill Mevacor to be sold without a prescription.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Rare diseases
Ultragenyx Takes Second Hit as FDA Rejects Gene Therapy for Sanfilippo Syndrome
July 14, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Mulls Speedier Reviews to Companies Willing To Lower Drug Costs
July 14, 2025
·
1 min read
·
Tristan Manalac
Complete response letters
Capricor Plunges on FDA Rejection of DMD Cell Therapy
July 11, 2025
·
3 min read
·
Tristan Manalac
FDA
FDA Rejections: We Read 200 CRLs So You Don’t Have To
July 11, 2025
·
5 min read
·
Annalee Armstrong